Growth without profits: the margin trap
Revenue surged 20%, but profits barely moved. Management credits temporary headwinds—yet every layer of the P&L shows compression, not recovery. The street's 7% fade by day 5 was disciplined.
₹165.2 Cr
on delivered result
~8% YoY
ex-Motocare prior-year one-time
+20.2% YoY
₹1,544.8 Cr
17.9% on VAR
-170 bps YoY
The headline reads like a blowout: ₹165.2 crore profit, revenues up 20%. The call suggests a confident franchise crushing the market. But dig into the numbers and a different story emerges. Profit growth is stuck at 8% organic, while revenue juggernaut races at 20%. That gap—between topline velocity and earnings leverage—is the quarter.
Where the growth went
EBITDA grew 7.9% YoY to ₹246.9 crore. But the margin—the profit per rupee of sales—fell from ~19.7% a year ago to 17.9% now. That 170-basis-point compression is not noise. It comes from two sources: public company costs (governance, compliance, listing infrastructure) estimated at ₹50–70 crore annually—a permanent structural burden—and unindexed commodity inflation (rubber, plastics, LPG, CNG, argon) where only 60 bps of recovery was negotiated with customers. The remainder is still unrecovered.
Management's claims, graded
Revenue growth outpaces the served addressable market
✓ SupportedRevenue +20.2% YoY vs. served market ~8–10% (adjusted for EV, Japanese OEM absence)
EBITDA margins resilient despite cost headwinds
✗ OverstatedMargin fell 170 bps YoY; only 60 bps of commodity recovery achieved
Strong market share gains across core businesses
✓ SupportedCV Clean Air 57%→58%, PV suspension 52%→55%, off-highway 68% maintained
PAT growth in line with EBITDA
✓ SupportedBoth ~8% organic; modest leverage despite 20% topline
Four new customers added to DaVinci platform
✓ SupportedConfirmed; these are new OEM entrants without prior conventional business
What changed on this call
Capacity utilization spiked to ART >90%, CAPT >80%—GST benefit to sub-4M affordable-segment vehicles driving demand beyond guidance
Export strategy crystallizing: 7% of Q1 revenue (~₹108 Cr), but 14–20% of order book. 70% internal (Tenneco-to-Tenneco), 30% third-party OEM
DCx platform penetration accelerating: 4 new customers in a single quarter. DaVinci32 now developed for A/B segment, broadening addressable market beyond premium
Margin pressure persistent: public company costs (₹50–70 Cr annually) now structural; commodity recovery timelines pushed out
If your commodity costs go up by INR10, and if you are able to recover INR10 from the customer, your margin percentage drops purely because of the numerator, denominator effect.
How the street read it
The stock opened at ₹580.7 on result-announcement day and promptly fell 1.75%. By day 3 it was down 4.5%; by day 5 it had retreated 6.9%. The fade never reversed. As of Aug 14, the stock trades at ₹538.25—down 18% from its all-time high of ₹657, despite 20% revenue growth. This repricing is not panic; it is discipline. Institutional investors (FII and DII) have stayed largely flat—FII added 75 bps of ownership to 9.69%, while DII trimmed 113 bps to 11.44%—but recent bulk activity on Aug 12 tells the real story: Tenneco Mauritius Holdings, a promoter-linked entity, sold 3.03 crore shares at ₹525.50, a signal that even the promoter sees limited upside from here. Offset by institutional buying (HDFC MF, SBI MF, others) at ₹525–₹530 levels, but the large promoter liquidation in a mid-range environment is a yellow flag.
The bull-bear ledger
✓ Market share leadership across all segments (CV, PV, off-highway); defensible moat in suspension tech (DCx proprietary platform)
✓ Topline growth (20.2% YoY) outpacing market, driven by DaVinci disruption and new OEM wins (4 in Q1 alone)
✓ Capacity expansion funded and underway (₹140 Cr capex for two plants); supply-side constraint near-term but resolvable
✗ EBITDA margin collapse (170 bps) not temporary; public company costs permanent, commodity recovery uncertain and mathematically challenged
✗ PAT growth (8% organic) lags revenue growth (20%) by 2.5×; earnings leverage broken; ROE and RoIC compressed
✗ Geopolitical headwinds (Middle East war, Trump tariffs on exhaust exports) and EV transition (~3–3.5% of addressable market already lost) unresolved
⚠ Management confidence on margin recovery timelines contradicted by Q1 delivery; order book opacity defers H1 validation
Risks ranked by holder concern
Margin recovery timelines slipping
HighEBITDA margin down 170 bps despite operational outperformance (revenue +20%). Public company costs (~₹50–70 Cr) are structural, not cyclical. Non-indexed commodity recovery stuck at 60 bps; full recovery uncertain. If margins stay at 17.9%, ROE and FCF yields decline materially vs. pre-IPO run-rate.
Earnings leverage broken
HighPAT growth (8%) trails revenue growth (20%) by 2.5×. This is the opposite of what a manufacturing company should deliver at scale. Suggests either pricing power loss or structural cost inflation. Multiples compress when growth ≠ earnings growth.
Geopolitical commodity and tariff escalation
Medium–HighMiddle East war sustains crude, LPG, CNG volatility. Trump Section 232 tariffs on exhaust exports dampen export margin. Export order book is 14–20% of total; tariff risk is material. No hedging strategy disclosed.
Capacity constraints limit near-term growth
MediumART >90%, CAPT >80% utilization. Despite strong demand (GST-driven A/B segment surge), supply bottleneck. New plants (₹70 Cr ART western, CAPT expansion) will take 12–18 months to ramp. If demand softens, capex becomes sunk cost.
Clean Air segment vulnerability
MediumClean Air growth 9.6% vs. served market 8–10%, a lag from historical outperformance. Japanese OEM absent until 2028–29 CAFE 3 entry. EV transition eroding addressable market (~3–3.5% already lost). Suspension upside (DaVinci) partially offsetting, but aftertreatment is 43% of revenue and slowing.
Order book opacity limits investor confidence
Low–MediumManagement refuses quarterly disclosure; deferring to H1 end and FY-end only. Stated reason (volatility smoothing) credible but limits forward visibility. Q2 order book disclosure is make-or-break for recovery narrative.
The debate
What to watch next
1 · Q2 FY27 order book disclosure (H1 end)
Management deferred order book granularity to H1. Expecting ₹12,400+ Cr (last reported), with 14–20% export mix. The 'mid-teens' to 'late-teens' growth trajectory on the ₹98.4 Cr pre-IPO book will signal forward momentum. A stall or contraction would break the bull case.
2 · EBITDA margin stabilization by Q3/Q4
Management guides for long-term recovery via product mix (DaVinci premium), localization, and operational efficiency (P3 model). Q2–Q3 margins need to hold at ~18% or recover to 18.5%+. Continued compression toward 17.5% signals the recovery is further away than acknowledged.
3 · New plant ramp timing and capex deployment
ART western plant (₹70 Cr) and CAPT expansion (₹70 Cr) are 12–18 months from start of revenue contribution. Early commissioning (H2 FY27) and customer ramp velocity will determine whether FY28 EBITDA margins inflect. Delays push recovery into FY29.
Tenneco delivered a steady operational quarter masked by margin compression. The 20% revenue growth is real and market-leading; the market share gains (CV, PV, off-highway) are tangible; the DCx disruption is durable. But earnings leverage is broken—profit growth at 8% is not compatible with 20% topline in a capital-light franchise. EBITDA margin down 170 bps, with only 60 bps recovered, signals structural cost headwinds. Public company costs are permanent. Geopolitical and tariff risks are unresolved.
The street's repricing (18% ATH drawdown, 7% post-result fade) reflects this reality. FII and DII are flat. Even the promoter (Tenneco Mauritius) is trimming at ₹525–₹536 levels, a vote of no-confidence in near-term upside.
Rating: Hold at ₹538. The bull case—technology leadership, new customer wins, export ramp—is intact but not yet enough to justify topline multiples. The bear case—broken earnings leverage, margin permanence, geopolitical risk—outweighs upside until management proves margin stabilization. The number to track: EBITDA margin in Q2. If it holds at 18%+ and the order book shows forward momentum, re-rate to Accumulate. If it falls below 17.5%, downgrade to Reduce. Until then, wait for H1 order book and FY28 guidance.
Informational and educational content only. Not investment advice.